Abstract:Background: Hepatitis B virus (HBV) infection is a significant global problem. The main therapies for chronic hepatitis B are nucleos(t)ide analogues (NAs) and (pegylated) interferon (IFN). However, the prognosis of chronic hepatitis B is still not so optimistic since the low serological conversion rate and the high recurrence rate after drug withdrawal.Objectives: This aim was to evaluate the killing activity of cytotoxic T lymphocytes (CTLs) induced by dendritic cells transduced recombinant adenovirus associated virus (rAAV) with different hepatitis B virus gene fragment (HBV-S, C, E, X).Methods: Peripheral blood mononuclear cells (PBMCs) were extracted from chronic hepatitis B patients, and the adhered cells were harvested to cultivate with recombinant adeno-associated virus with different hepatitis B virus (HBV) antigen gene fragment (rAAV-HBV-S, C, E, X) for 7 days by adding GM-CSF, IL-4 and TNF-alpha to generate mature dendritic cells (DCs). The DCs' state were observed and their differentiation antigen molecules (CD) were detected by flow cytometry (FACS) to evaluate their maturation and function. DCs were co-cultured with prepared T lymphocytes to induce cytotoxic T lymphocytes (CTLs). The activity of CTLs induced by different DCs were compared by detection of lymphocyte CD molecules and cytokine levels. HepaG2.2.15 cells were target cells and HepaG2 cells as control. The specific killing activity of CTLs were compared by cell killing assay using 3-(4, 5-dimethylthiazol-2yl)- 5(3-carboxymethoxyphenyl)-2-(4-sulfopheny)-2H-tetrazolium (MTS).Results: The expression of phenotype CD14, CD80, CD83, CD86 from DCs transduced with rAAV-HBV-S, C, E, X and the secretion of cytokine IL-10, IL-12 were compared, respectively. CD80 in rAAV-HBV-S was the highest (P < 0.05), and CD83 in rAAV-HBV-X was the highest (P< 0.05), but other results were not significantly different (P > 0.05). The response of cytotoxic T-lymphocytes induced by different adeno-associated virus (AAV) vector delivery into dendritic cells had significant differences. In comparing the four antigens in terms of CD4+ CD25+ T cells, it was found that rAAV HBV-E group was the highest, and rAAV HBV-X group was the lowest (P < 0.05); CD8+ CD69 + T cells in rAAV HBV-X group was the highest, and rAAV HBV-S group was the lowest (P < 0.05); IFN-gamma levels secreted by CTLs in rAAV HBV-X group was the highest, and rAAV HBV-S group was the lowest (P < 0.05). The specific cell killing activity of CTLs induced by DCs transduced by rAAV-HBV-X to the HepaG2.2.15 cells was the highest, but the four groups were no significant difference, respectively (P > 0.05).Conclusions: These data suggest that rAAV-HBV-S, C, E, Xdelivery into DC may be all useful for immunotherapeutic strategies against hepatitis B virus infection and that the HBV X antigen gene may be the most useful.

Induction of Tc1 Response and Enhanced Cytotoxic T Lymphocyte Activity in Mice by Dendritic Cells Transduced with Adenovirus Expressing HBsAg

Immune Response Against Hepatitis B Virus Induced by HBsAg Recombinant Adenovirus-Transduced Dendritic Cells in BALB/c Mice

Immunostimulatory activities of dendritic cells loaded with adenovirus vector carrying HBcAg/HBsAg.

Study on the Immune Response Induced by Hbcag Gene-Modified Dendritic Cells in Hepatitis B Virus Transgenic Mice

TBK-1 Enhances Humoral and Cellular Immune Responses in Mice Induced by DNA Vaccination of HBV Core Gene

Induction of Tumor Immunity and Cytotoxic T Lymphocyte Responses Using Dendritic Cells Transduced by Adenoviral Vectors Encoding HBsAg: Comparison to Protein Immunization

Dendritic Cell Generated from CD34+ Hematopoietic Progenitors Can Be Transfected with Adenovirus Containing Gene of HBsAg and Induce Antigen-Specific Cytotoxic T Cell Responses.

Therapeutic Potential of Dendritic Cell-Based Immunization Against HBV in Transgenic Mice

Adenovirus Vector Harboring the HBcAg and Tripeptidyl Peptidase II Genes Induces Potent Cellular Immune Responses In Vivo.

Recognition of HBV antigens and HBV DNA by dendritic cells.

Dendritic Cell-Based Vaccination with Lentiviral Vectors Encoding Ubiquitinated Hepatitis B Core Antigen Enhances Hepatitis B Virus-Specific Immune Responses in Vivo

Hepatitis B virus core antigen epitopes presented by HLA-A2 single-chain trimers induce functional epitope-specific CD8<sup>+</sup>T-cell responses in HLA-A2·1/Kb transgenic mice

Hepatitis B Virus Core Antigen Epitopes Presented By Hla-A2 Single-Chain Trimers Induce Functional Epitope-Specific Cd8(+) T-Cell Responses In Hla-A2.1/Kb Transgenic Mice

Enhancement of Cytotoxic T Lymphocyte Activity by Dendritic Cells Loaded with Tat-protein Transduction Domain-Fused Hepatitis B Virus Core Antigen

Immunization with Lentiviral Vector‑modified Dendritic Cells Encoding Ubiquitinated Hepatitis B Core Antigen Promotes Th1 Differentiation and Antiviral Immunity by Enhancing P38 MAPK and JNK Activation in HBV Transgenic Mice.

The Delivery of HBcAg Via Tat-PTD Enhances Specific Immune Response and Inhibits Hepatitis B Virus Replication in Transgenic Mice.

Enhancement of CTLs induced by DCs loaded with ubiquitinated hepatitis B virus core antigen.

HBcAg-pulsed Dendritic Cell Vaccine Induces Th1 Polarization and Production of Hepatitis B Virus-Specific Cytotoxic T Lymphocytes.

Generation of Adenovirus -Mediated HBsAg Gene Modified Dendritic Cells

[Impact of Different Adjuvants on Immunogenicity of the HBV Particle Vaccine Containing the S + Pres1 Fusion Antigen in Balb/C Mice].

Effect of Cytotoxic T Lymphocytes Induced by Recombinant Adeno-Associated Virus on Different Hepatitis B Virus Genes